Lack of BCL-2 confers interferon-alpha sensitivity to B-cell lymphomas

References

• İsaacs A, Lindenmann J. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 1957; 147(927)258–267, Sep 12
   PubMed Web of Science ®Google Scholar
• Robak T. Current treatment options in hairy cell leukemia and hairy cell leukemia variant. Cancer Treat Rev 2006; 32(5)365–376
   PubMed Web of Science ®Google Scholar
• Spielberger MJ, Mick R, Ratain MJ, Golomb HM. Interferon treatment for hairy cell leukemia. An update on a cohort of 69 patients treated from 1983 to 1986. Leuk Lymphoma 1994; 14(Suppl. 1)89–93
   PubMed Web of Science ®Google Scholar
• Seymour JF, Estey EH, Ratain MJ, Kurzrock R. Response to interferon-alpha in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine. Leukemia 1995; 9(5)929–932
   PubMed Web of Science ®Google Scholar
• Damasio MM, Clavio M, Masoudi B, Isaza A, Spriano M, Rossi E, Casciaro S, Cerri R, Risso M, Nati S, Siccardi M, Truini M, Gobbi M. Alpha-interferon as induction and maintenance therapy in hairy cell leukemia: A long-term follow-up analysis. Eur J Haematol 2000; 64(1)47–52
   PubMed Web of Science ®Google Scholar
• Rai KR, Davey F, Peterson B, Schiffer C, Silver RT, Ozer H, Golomb H, Bloomfield CD. Recombinant alpha-2b-interferon in therapy of previously untreated hairy cell leukemia: Long-term follow-up results of study by Cancer and Leukemia Group B. Leukemia 1995; 9(7)1116–1120
   PubMed Web of Science ®Google Scholar
• Abramson JS, Shipp MA. Advances in the biology and therapy of diffuse large B-cell lymphoma: Moving toward a molecularly targeted approach. Blood, 106(4)1164–1174
   PubMed Web of Science ®Google Scholar
• Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 2002; 9(3)459–470
   PubMed Web of Science ®Google Scholar
• Graninger WB, Seto M, Boutain B, Goldman P, Korsmeyer SJ. Exression of Bcl-2 and Bcl-2-Ig fusion transcripts in normal and neoplastic cells. J Clin Invest 1987; 80(5)1512–1515
   PubMed Web of Science ®Google Scholar
• Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335(6189)440–442, Sep 29
   PubMed Web of Science ®Google Scholar
• Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood 1992; 80(4)879–886, Aug 15
   PubMed Web of Science ®Google Scholar
• Rathmell JC, Thompson CB. The central effectors of cell death in the immune system. Annu Rev Immunol 1999; 17: 781–828
   PubMed Web of Science ®Google Scholar
• Cory S, Adams JM. Bcl2 family: Regulators of the cellular life-or-death switch. Nat Rev Cancer 2002; 2(9)647–656
   PubMed Web of Science ®Google Scholar
• Ozes ON, Klein SB, Reiter Z, Taylor MW. A comparison of interferon-Con1 with natural recombinant interferons-alpha: Antiviral, antiproliferative, and natural killer-inducing activities. J Interferon Res 1992; 12(1)55–59
   PubMedGoogle Scholar
• Ozes ON, Klein SB, Reiter Z, Taylor MW. An interferon resistant variant of the hairy-cell leukemia cell line. Eskol: Biochemical and immunological characterization. Leuk Res 1993; 17(11)983–990
   PubMed Web of Science ®Google Scholar
• Breckenridge DG, Xue D. Regulation of mitochondrial membrane permeabilization by BCL-2 family proteins and caspases. Curr Opin Cell Biol 2004; 16(6)647–652
   PubMed Web of Science ®Google Scholar
• Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 1993; 75(4)641–652, Nov 19
   PubMed Web of Science ®Google Scholar
• Martinon F, Tschopp J. Inflammatory caspases: Linking an intracellular innate immune system to autoinflammatory diseases. Cell 2004; 117(5)561–574, May 28
   PubMed Web of Science ®Google Scholar
• Kondo S, Barna BP, Morimura T, Takeuchi J, Yuan J, Akbasak A, Barnett GH. Interleukin-1 beta-converting enzyme mediates cisplatin-induced apoptosis in malignant glioma cells. Cancer Res 1995; 55(24)6166–6171, Dec 15
   PubMed Web of Science ®Google Scholar
• Poyet JL, Srinivasula SM, Tnani M, Razmara M, Fernandes-Alnemri T, Alnemri ES. Identification of Ipaf, a human caspase-1-activating protein related to Apaf-1. J Biol Chem 2001; 276(30)28309–28313, Jul 27
   PubMed Web of Science ®Google Scholar
• Thome M, Hofmann K, Burns K, Martinon F, Bodmer JL, Mattmann C, Tschopp J. Identification of CARDIAK, a RIP-like kinase that associates with caspase-1. Curr Biol 1998; 8(15)885–888, Jul 16
   PubMed Web of Science ®Google Scholar
• Srinivasula SM, Poyet JL, Razmara M, Datta P, Zhang Z, Alnemri ES. The PYRIN–CARD protein ASC is an activating adaptor for caspase-1. J Biol Chem 2002; 277(24)21119–21122, Jun 14
   PubMed Web of Science ®Google Scholar
• Yoo NJ, Park WS, Kim SY, Reed JC, Son SG, Lee JY, Lee SH. Nod1 a CARD protein, enhances pro-interleukin-1beta processing through the interaction with pro-caspase-1. Biochem Biophys Res Commun 2002; 299(4)652–658, Dec 13
   PubMed Web of Science ®Google Scholar
• Mariathasan S, Newton K, Monack DM, Vucic D, French DM, Lee WP, Roose-Girma M, Erickson S, Dixit VM, Differential. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 2004; 430(6996)213–218, Jul 8
   PubMed Web of Science ®Google Scholar
• Sadasivam S, Gupta S, Radha V, Batta K, Kundu TK, Swarup G. Caspase-1 activator Ipaf is a p53-inducible gene involved in apoptosis. Oncogene 2005; 24(4)627–636, Jan 20
   PubMed Web of Science ®Google Scholar
• Gupta S, Radha V, Furukawa Y, Swarup G. Direct transcriptional activation of human caspase-1 by tumor suppressor p53. J Biol Chem 2001; 276(14)10585–10588, Apr 6
   Google Scholar
• Harvey WH, Harb OS, Kosak ST, Sheaffer JC, Lowe LR, Heerema NA. Interferon-alpha-2b downregulation of oncogenes H-ras, c-raf-2, c-kit, c-myc, c-myb and c-fos in ESKOL, a hairy cell leukemic line, results in temporal perturbation of signal transduction cascade. Leuk Res 1994; 18(8)577–585
   PubMed Web of Science ®Google Scholar
• Akca H, Ozes ON. Eoudernal growth factor suppresses interferon-induced accumulation of p53 and p21 by using protein kinase C. Scand J Clin Lab Invest 2003; 63(7-8)505–512
   PubMed Web of Science ®Google Scholar
• Kanzaki M, Morris PL. Identification and regulation of testicular interferon-gamma (IFNgamma) receptor subunits: IFNgamma enhances interferon regulatory factor-1 and interleukin-1beta converting enzyme expression. Endocrinol 1998; 139(5)2636–2644
   PubMed Web of Science ®Google Scholar
• Karlsen DL, Pavlovic J. Interfron-gamma induces interleukin-1 converting enzyme expression in pancreatic islets by an interferon regulatory factor-1-dependent mechanism. J Clin Endocrinol Metab 2000; 85(2)830–836
   PubMed Web of Science ®Google Scholar